Mobilization and harvesting of PBPC in newly diagnosed type 1 diabetes mellitus

Bone Marrow Transplantation

Volumn 47, Issue 7, 2012, Pages 993-994

  De Santis, G C ^a,b   De Pina Almeida Prado, B ^a,b   De Lima Prata, K ^a,b   Brunetta, D M ^a,b   Orellana, M D ^a,b   Palma, P V B ^a   Oliveira, M C ^b   Simoes, B P ^b   Voltarelli, J C ^a,b   Covas, D T ^a,b  

^a National Institute of Science and Technology in Stem Cell and Cell Therapy   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; APHERESIS; CD34 SELECTION; CHILL; CLINICAL ARTICLE; FEBRILE NEUTROPENIA; FEMALE; HEADACHE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MALAISE; MALE; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; TISSUE AND ORGAN HARVESTING; YOUNG ADULT;

EID: 84863726176     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.188     Document Type: Letter

References (10)

1. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
2. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297: 1568-1576.
3. Pusic I, DiPersio JF. The use of growth factors in hematopoietic stem cell transplantation. Curr Pharm Des 2008; 14: 1950-1961.
4. Jantunen E, Kuittinen T. Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues. Eur J Haematol 2008; 80: 287-295.
5. Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T et al. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 317-329.
6. Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1-12.
7. Stiff PJ. Management strategies for the hard-to-mobilize patient. Bone Marrow Transplant 1999; 23(Suppl 2): S29-S33.
8. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
9. Moog R. Mobilization and harvesting of peripheral blood stem cells. Curr Stem Cell Res Ther 2006; 1: 189-201.
10. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009; 113: 3604-3611.